title: Unusual and early hyperglycemia following amiodarone infusion in two infants.
abstract: Amiodarone is an effective antiarrhythmic agent that is widely used for tachyarrhythmias, especially ventricular tachycardia and supraventricular tachycardia. It has some mild short-term (e.g., skin rashes, gastrointestinal symptoms, and corneal microdeposits) and long-term side effects (thyroid dysfunction, visual disturbances, pulmonary infiltrates, ataxia, and hepatitis). We present two infants who had hyperglycemia following amiodarone infusion during the early postoperative period.
authors.affiliation: Division of Pediatric Cardiology, Baskent University, Faculty of Medicine, Ankara, Turkey. svefay@yahoo.com
authors.forename: S V
authors.initials: SV
authors.lastname: Yildirim
authors.forename: E
authors.initials: E
authors.lastname: Azak
authors.forename: B
authors.initials: B
authors.lastname: Varan
authors.forename: K
authors.initials: K
authors.lastname: Tokel
mesh_terms: D000638:Amiodarone / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D006348:Cardiac Surgical Procedures; D005260:Female; D006345:Heart Septal Defects, Ventricular / Q000601:surgery; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced*; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D013617:Tachycardia, Supraventricular / Q000188:drug therapy / Q000209:etiology; D014188:Transposition of Great Vessels / Q000601:surgery; D014693:Ventricular Fibrillation / Q000188:drug therapy / Q000209:etiology
chemical_list: D000889:Anti-Arrhythmia Agents; D000638:Amiodarone